Ge Healthcare Technologies INC Form 4 insider transactions

GE HealthCare Technologies Inc. reports a Form 4 filing detailing a Director's acquisition of common stock.

Jeannette Bankes, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reported a transaction involving the sale of 5,535 shares of common stock.

GE HealthCare Technologies Inc. director Rodney F. Hochman reported the acquisition of 1,618 shares of common stock on May 12, 2026.

GE HealthCare Director Phoebe L. Yang acquired 4,586 shares through a combination of an RSU grant and open market purchases.

GE HealthCare Technologies Inc. director H. Lawrence Culp Jr. acquired 7,743 shares through restricted and deferred stock unit awards.

GE HealthCare Technologies Inc. director Rodney F. Hochman acquired 6,275 shares through restricted and deferred stock unit awards.

Director Catherine Lesjak was granted 3,586 restricted stock units as part of GE HealthCare Technologies Inc. compensation.

Director Kevin Lobo acquired 3,586 restricted stock units in GE HealthCare Technologies Inc. as part of a standard equity grant.

Director Anne T. Madden acquired 5,868 shares of GE HealthCare common stock through restricted and deferred stock unit awards.

GE HealthCare Technologies Inc. director William J. Stromberg was granted 3,586 restricted stock units as part of director compensation.

GE HealthCare Technologies Inc. reports a Form 4 filing detailing a stock purchase by Director William J. Stromberg.

GE HealthCare Technologies Inc. CFO James Saccaro purchased 3,310 shares of common stock at an average price of $60.5997.

GE HealthCare Technologies Inc. President and CEO Peter J. Arduini purchased 4,169 shares of common stock.

GE HealthCare Technologies Inc. Director Kevin Lobo received an award of 777 restricted stock units, vesting by March 2027, aligning his interests with shareholders.

GE HealthCare Technologies Inc.'s CEO of Patient Care Solutions, Jeannette Bankes, was granted 6,861 restricted stock units and 18,038 employee stock options.

GE HealthCare Technologies Inc.'s General Counsel, Frank R. Jimenez, was granted 10,915 restricted stock units and 28,697 employee stock options.

GE HealthCare Technologies Inc.'s Chief Technology Officer, Taha Kass-Hout, received awards of restricted stock units and employee stock options.

GE HealthCare's Chief People Officer, Adam Y. Holton, was granted 5,457 restricted stock units and 14,348 employee stock options.

GE HealthCare's Chief Accounting Officer, George A. Newcomb, increased his beneficial ownership through new restricted stock unit and employee stock option awards.

GE HealthCare Technologies Inc. CEO Kevin Michael O'Neill received an award of 6,549 restricted stock units and 17,218 employee stock options.

Philip Rackliffe, CEO of AVS at GE HealthCare Technologies Inc., was granted 9,356 restricted stock units and 24,598 employee stock options.

GE HealthCare Technologies Inc. granted CEO of Imaging, Roland Rott, 8,576 restricted stock units and 22,548 employee stock options.

GE HealthCare Technologies Inc. Chief Financial Officer James Saccaro was granted 12,475 restricted stock units and 32,797 employee stock options.

GE HealthCare Technologies Inc. CEO Peter J. Arduini received substantial equity awards and stock options, aligning executive incentives with long-term company performance.

GE HealthCare Technologies Inc. CEO, PDx Kevin Michael O'Neill reported a planned disposition of 462 shares of common stock for tax withholding related to RSU vesting.

GE HealthCare Technologies Inc.'s CEO, AVS, Philip Rackliffe, plans to dispose of 189 shares of common stock on February 1, 2026, to cover tax withholding obligations related to restricted stock unit vesting.

GE HealthCare Technologies Inc.'s Chief Technology Officer, Taha Kass-Hout, disposed of 847 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

GE HealthCare Technologies' Chief Accounting Officer, George A. Newcomb, disposed of 108 shares of common stock to cover tax obligations related to restricted stock unit vesting.

GE HealthCare Technologies Inc.'s CEO of Imaging, Roland Rott, disposed of 558 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

GE HealthCare's General Counsel, Frank R. Jimenez, disposed of 947 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.